SINEW PHARMA INC. (stock code: 6634.TWO) is a publicly-listed biotech company dedicated on the development of therapeutic products for solving urgent and important unmet medical needs. SINEW aspires to become a leading pharmaceutical company by actively engaging in R&D for drug development of metabolic dysfunction-associated steatohepatitis, MASH (formerly known as non-alcoholic steatohepatitis, NASH) as well as for the world's first non-hepatotoxic acetaminophen. Current pipeline includes six products, two of which are dedicated to MASH treatment, three aim to address liver toxicity issues arising from the widely used painkiller acetaminophen and its combinations (e.g., with a non-addictive kappa-opioid for postoperative pain management), and one serves as an antidote for acetaminophen poisoning.
| Website | https://www.sinewpharma.com/en/ |
| Employees | 17 (7 on RocketReach) |
| Founded | 2014 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Therapeutics, Pharmaceutical Research, Drug Development, Clinical Trials, Biopharma, Medical Innovation, Health Solutions, Pharmaceutical Products, New Drugs, Prescription Drugs, Human Health, Disease Treatment, Healthcare, Life Sciences, Biotechnology Research, Drug Discovery, Patient Care |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Bristol Myers Squibb, Amgen, Gilead Sciences +45 more (view full list) |
Looking for a particular Sinew Pharma employee's phone or email?
Sinew Pharma Questions
Krisztina Gyimes is the Director of Business Development of Sinew Pharma.
7 people are employed at Sinew Pharma.
Top Sinew Pharma Employees
-
Chang-Hui Tsao
Deputy Director of R and D at Sinew Pharma
Taipei City, Taiwan1 -
Yu-Shiuan Wang
資深研究員 at Sinew Pharma
Taipei City, Taiwan -
Cheng-Huei Hsiong
Vice President and Chief R&D Officer at Sinew Pharma
Taipei City, Taiwan, Taiwan1
Related Companies
